Male breast cancer. A report of 71 cases

Cancer/Radiotherapie

Volumn 6, Issue 6, 2002, Pages 349-351

  El Omari Alaoui, H ^a   Lahdiri, I ^a   Nejjar, I ^a   Hadadi, K ^a   Ahyoud, F ^a   Hachi, H ^a   Alhilal, M ^a   Errihani, H ^a   Benjaafar, N ^a   Souadka, A ^a   El Gueddari, B K ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

Author keywords

Male breast cancer; Prognostic factors; Treatment

Indexed keywords

HORMONE; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; BREAST AREOLA; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INFILTRATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MOROCCO; PATIENT CARE; PLEURA METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SKIN METASTASIS; TIME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; MALE; MASTECTOMY, RADICAL; MIDDLE AGED; MOROCCO; NEOPLASM METASTASIS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 0036932004     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(02)00250-0     Document Type: Article

References (14)

1. English JC, Middleton C, Patterson JW, Slingluff CL. Cancer of the male breast. Int J Dermatol 2000;39:881-6.
2. Herman K, Labaziewicz W, Scotnicki P, Fortuna J, Kusy T, Lesniak T, et al. Male breast cancer. Does the prognosis differ compared to female? Neoplasma 2000;47(3):191-5.
3. Ravandi-Kashani F, Hayes TG. Male breast cancer: Review of the literature. Eur J Cancer 1998;34(9):1341-7.
4. Osorio A, Barroso A, Martinez B, Cebrian A, Roman JM, Lobo F, et al. Molecular analysis of the BRCA1 and BRACA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 2000;82(7):1266-70.
5. Winchester DJ. Male breast carcinoma. A multiinstitutional challenge. Cancer 1998;83(3):399-400.
6. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast. A multiinstitutional survey. Cancer 1998;83(3):498-509.
7. Donegan WL. Cancer of the male breast. J Gend Specif Med 2000;3(4):55-8.
8. Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 1994;74(1):74-7.
9. Vetto J, Jun SY, Padduch D, Eppich H, Shih R, Oregan P, et al. Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 1999;177:379-83.
10. Stranzl H, Mayer R, Quehenberger F, Prettenhofer U, Willfurth P, Stoger H, et al. Adjuvant radiotherapy in male breast cancer. Radiother Oncol 1999;53(1):29-35.
11. Jepson AS, Fentiman IS. Male breast cancer. IJCP 1998;52(8):571-6.
12. El Hajjam M, Khaiz D, Benider A, Lakhloufi A, Abi F, Kahlain A, et al. Cancer du sein chez l'homme. A propos de 50 observations. J Chirurg 1995;132(3):131-6.
13. Haraldsson K, Loman N, Zhan QX, Johansson O, Olsson H, Borg A, et al. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of disease. Cancer Res 1998;58(7):1367-71.
14. Tajima N, Tsukuma H, Oshima A. Descriptive epidemiology of male breast cancer in Osaka, Japan. J Epidemiol 2001;11(1):1-7.